Table 2.
a) Hazard ratios for OS |
b) Hazard ratios for PFS |
|||
---|---|---|---|---|
Parameter | Hazard ratio (95% CI) | P-value | Hazard ratio (95% CI) | P-value |
Age | 1.00 (0.99, 1.02) | 0.701 | 1.00 (0.98, 1.01) | 0.73 |
Sex (female) | 0.77 (0.50, 1.18) | 0.228 | 0.90 (0.60, 1.34) | 0.598 |
Karnofsky Index | 0.99 (0.98, 1.01) | 0.514 | 1.00 (0.98, 1.01) | 0.575 |
T3 | 1.54 (0.95, 2.49) | 0.005 | 1.51 (0.96, 2.36) | 0.006 |
T4 | 2.43 (1.39, 4.22) | 2.32 (1.37, 3.94) | ||
N1 | 1.38 (0.89, 2.14) | 0.293 | 1.24 (0.75, 1.87) | 0.601 |
N2/3 | 1.46 (0.87, 2.46) | 1.24 (0.75, 2.03) | ||
M1 | 1.56 (1.09, 2.23) | 0.015 | 1.69 (1.19, 2.39) | 0.003 |
G3/4 | 1.06 (0.78, 1.45) | 0.709 | 1.10 (0.81, 1.49) | 0.534 |
Initial hemoglobin | 0.96 (0.89, 1.03) | 0.255 | 0.95 (0.88, 1.02) | 0.136 |
Localization | 1.00 (0.98, 1.03) | 0.711 | 1.00 (0.97, 1.02) | 0.83 |
Histologic subtype (AC) | 0.86 (0.56, 1.32) | 0.499 | 0.95 (0.62, 1.45) | 0.812 |
Total radiation dose (>55 Gy) | 0.68 (0.49, 0.94) | 0.019 | 0.69 (0.51, 0.95) | 0.022 |
Chemotherapy (yes) | 0.38 (0.27, 0.54) | <0.001 | 0.44 (0.31, 0.63) | <0.001 |
Immunotherapy (Cetuximab) (yes) | 0.45 (0.24, 0.83) | 0.011 | 0.61 (0.34, 1.09) | 0.097 |